Medical uncertainty and practice variation get personal: What should I do about hormone replacement therapy?

被引：7

作者：

Daley, J ^{[1
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

来源：

ANNALS OF INTERNAL MEDICINE | 1999年 / 130卷 / 07期

关键词：

D O I：

10.7326/0003-4819-130-7-199904060-00021

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The results of Keating and colleagues' study, reported in this issue, suggest that we may have many more questions to ask and answer about our female patients and how we collaborate with them to find out whether they should use hormone replacement therapy.

引用

页码：602 / 604

页数：3

共 13 条

[1] Patient-specific decisions about hormone replacement therapy in postmenopausal women
Col, NF
Eckman, MH
Karas, RH
Pauker, SG
Goldberg, RJ
Ross, EM
Orr, RK
Wong, JB
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (14): : 1140 - 1147
[2] Treatment of postmenopausal osteoporosis
Eastell, R
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (11) : 736 - 746
[3] Eddy D M, 1984, Health Aff (Millwood), V3, P74, DOI 10.1377/hlthaff.3.2.74
[4] ESTROGEN AND PROGESTIN THERAPY TO PREVENT OSTEOPOROSIS - ATTITUDES AND PRACTICES OF GENERAL INTERNISTS AND GYNECOLOGISTS
GREENDALE, GA
CARLSON, KJ
SCHIFF, I
[J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 1990, 5 (06) : 464 - 469
[5] Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
Grodstein, F
Stampfer, MJ
Manson, JE
Colditz, GA
Willett, WC
Rosner, B
Speizer, FE
Hennekens, CH
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (07) : 453 - 461
[6] Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
Hulley, S
Grady, D
Bush, T
Furberg, C
Herrington, D
Riggs, B
Vittinghoff, E
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07): : 605 - 613
[7] Use of hormone replacement therapy by postmenopausal women in the United States
Keating, NL
Cleary, PD
Rossi, AS
Zaslavsky, AM
Ayanian, JZ
[J]. ANNALS OF INTERNAL MEDICINE, 1999, 130 (07) : 545 - 553
[8] Alendronate prevents postmenopausal bone loss in women without osteoporosis - A double-blind, randomized, controlled trial
McClung, M
Clemmesen, B
Daifotis, A
Gilchrist, NL
Eisman, J
Weinstein, RS
El-Hajj Fuleihan, G
Reda, C
Yates, AJ
Ravn, P
[J]. ANNALS OF INTERNAL MEDICINE, 1998, 128 (04) : 253 - +
[9] Mort EA, 1996, J FAM PRACTICE, V42, P147
[10] EFFECT OF SALCATONIN GIVEN INTRANASALLY ON BONE MASS AND FRACTURE RATES IN ESTABLISHED OSTEOPOROSIS - A DOSE-RESPONSE STUDY
OVERGAARD, K
HANSEN, MA
JENSEN, SB
CHRISTIANSEN, C
[J]. BRITISH MEDICAL JOURNAL, 1992, 305 (6853) : 556 - 561

← 1 2 →